Biohaven Ltd.
BHVN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001935979
No open-market purchases or sales by Biohaven Ltd. insiders were filed in the last 90 days; 297 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Biohaven Ltd. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 189
- +10 vs. Q1 2023
- Shares held
- 60.9M
- −6.21M (−9.3%) vs. Q1 2023
- Total value
- $1.45B
- +$532.2M (+57.8%) vs. Q1 2023
- New holders
- 36
- 48 more added
- Sold out
- 26
- 66 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BHVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 297 | $2.13B |
| Q1 2026 | 279 | $1.22B |
| Q4 2025 | 275 | $1.40B |
| Q3 2025 | 266 | $1.28B |
| Q2 2025 | 251 | $1.24B |
| Q1 2025 | 267 | $2.24B |
| Q4 2024 | 258 | $3.51B |
| Q3 2024 | 257 | $4.34B |
| Q2 2024 | 228 | $2.90B |
| Q1 2024 | 245 | $4.09B |
| Q4 2023 | 220 | $3.09B |
| Q3 2023 | 188 | $1.61B |
| Q2 2023 | 189 | $1.45B |
| Q1 2023 | 180 | $921.1M |
| Q4 2022 | 183 | $882.3M |
| Q3 2022 | 277 | $9.26B |
| Q2 2022 | 330 | $8.96B |
| Q1 2022 | 306 | $7.58B |
| Q4 2021 | 284 | $8.55B |
| Q3 2021 | 250 | $8.17B |
| Q2 2021 | 223 | $5.80B |
| Q1 2021 | 225 | $4.10B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Biohaven Ltd.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 0 | $0 | 0.00% | −5,741−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,107−100.0% | Sold out |
| Hollencrest Capital Management | 0 | $0 | 0.00% | −840−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −157−100.0% | Sold out |
| Sandy Spring Bank | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Schubert & Co | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | 0 | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| LeJeune Puetz Investment Counsel LLC | – | – | – | – | Not filed |